Heterocyclic aspartyl protease inhibitors

Disclosed are compounds of the formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein each variable in Formula 1 are as defined in the specification; and pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GU HUIZHONG, LIU XIAOIANG, TADESSE DAWIT, VOIGHT JOHANNES H, GUO TAO, LE THUY X. E, WU YUSHENG, DUO JINGQI, SUN ZHONG-YUE, ZHU ZHAONING, SAIONZ KURT W, SHAO YUEFEI, STAMFORD ANDREW W, HUNTER RACHAEL C, MISIASZEK JEFFREY A, LAI GAIFA, CUMMING JARED N, HUANG YING, MAZZOLA, JR. ROBERT D, PAN JIANPING, CALDWELL JOHN P, ISERLOH ULRICH, BABU SURESH D, GREENLEE WILLIAM J, SMITH ELIZABETH M, MORRIS MICHELLE L, MCKITTRICK BRIAN, QIAN GANG, LI GUOQING, QU CHUANXING, STRICKLAND COREY O, YE YUANZAN C, WANG LINGYAN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!